Limited GMP Certificate of Sanochemia Pharmazeutika AG

The listed company Sanochemia Pharmazeutika AG, Vienna (ISIN AT0000776307, ISIN DE000A1G7JQ9), announces that the GMP certificate of Sanochemia Pharmazeutika AG has been restricted to 11.04.2018 according to the EUDRA GMP database.

The restriction relates to the production of individual drugs and their quality control. For the period of restriction, this production and its testing will be outsourced and the production of the affected medicinal products will be gradually resumed after approval.

The company has not yet received a written notification from the Federal Office for Safety in Health Care (BASG). A complete and final substantive examination will be possible on the basis of the written notice. The Company reserves the right to appeal the decision.